Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christopher Lieu

Concepts (416)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
53
2026
844
9.880
 Why?
Antineoplastic Combined Chemotherapy Protocols
25
2026
1953
2.760
 Why?
Colonic Neoplasms
9
2026
259
2.700
 Why?
Biomarkers, Tumor
23
2026
1313
2.410
 Why?
Molecular Targeted Therapy
9
2019
431
1.890
 Why?
Antineoplastic Agents
14
2021
2192
1.830
 Why?
Antibodies, Monoclonal, Humanized
12
2026
985
1.710
 Why?
Rectal Neoplasms
7
2023
156
1.610
 Why?
Bevacizumab
5
2024
167
1.570
 Why?
Immunotherapy
5
2026
652
1.530
 Why?
Benzimidazoles
3
2024
190
1.470
 Why?
Neoplasms
14
2025
2870
1.410
 Why?
Microsatellite Instability
11
2026
54
1.120
 Why?
Drug Resistance, Neoplasm
10
2026
881
1.120
 Why?
Pancreatic Neoplasms
11
2025
918
1.070
 Why?
Mutation
15
2025
4085
1.030
 Why?
Circulating Tumor DNA
5
2026
43
1.010
 Why?
Neoplasm Staging
14
2026
1461
0.990
 Why?
Age of Onset
9
2024
536
0.970
 Why?
Gastrointestinal Neoplasms
2
2025
70
0.960
 Why?
Tankyrases
1
2025
13
0.920
 Why?
Cetuximab
5
2025
111
0.830
 Why?
Neuroendocrine Tumors
6
2024
112
0.830
 Why?
Vascular Endothelial Growth Factor A
4
2020
557
0.830
 Why?
Fluorouracil
8
2026
235
0.780
 Why?
Proto-Oncogene Proteins p21(ras)
4
2019
253
0.780
 Why?
Humans
109
2026
144261
0.780
 Why?
Oncologists
1
2023
46
0.760
 Why?
Proto-Oncogene Proteins B-raf
6
2024
225
0.740
 Why?
Indoles
1
2025
501
0.690
 Why?
Antibodies, Monoclonal
6
2023
1519
0.670
 Why?
Leucovorin
7
2026
101
0.650
 Why?
Middle Aged
45
2026
35762
0.650
 Why?
Carcinoma, Pancreatic Ductal
4
2025
291
0.640
 Why?
Wnt Signaling Pathway
3
2025
210
0.640
 Why?
Pyrimidinones
2
2024
126
0.630
 Why?
Aged
36
2026
25850
0.620
 Why?
Colectomy
2
2026
107
0.610
 Why?
DNA Mismatch Repair
5
2026
52
0.610
 Why?
Camptothecin
5
2025
140
0.600
 Why?
Pyridones
2
2024
198
0.590
 Why?
Early Detection of Cancer
4
2025
462
0.580
 Why?
Neoplasm Metastasis
9
2025
688
0.580
 Why?
Disease-Free Survival
8
2026
768
0.560
 Why?
Piperidines
2
2017
217
0.560
 Why?
Adult
40
2026
40262
0.550
 Why?
Neoadjuvant Therapy
6
2026
462
0.530
 Why?
Azetidines
1
2017
44
0.510
 Why?
Cyclosporine
1
2018
265
0.510
 Why?
Genetic Predisposition to Disease
4
2022
2359
0.510
 Why?
Appendiceal Neoplasms
2
2020
28
0.500
 Why?
Terminology as Topic
1
2019
255
0.500
 Why?
Chemotherapy, Adjuvant
6
2026
419
0.490
 Why?
Male
47
2026
72035
0.480
 Why?
Precision Medicine
2
2026
456
0.470
 Why?
Neoplasms, Unknown Primary
2
2026
20
0.460
 Why?
Female
48
2026
77976
0.460
 Why?
MAP Kinase Kinase Kinases
1
2015
70
0.450
 Why?
Adrenal Gland Neoplasms
3
2022
91
0.450
 Why?
Patient Rights
1
2015
11
0.450
 Why?
Treatment Outcome
16
2026
11643
0.440
 Why?
Kaplan-Meier Estimate
7
2025
964
0.440
 Why?
Medical Oncology
5
2023
331
0.440
 Why?
Drug and Narcotic Control
1
2015
24
0.440
 Why?
Therapies, Investigational
1
2015
18
0.440
 Why?
Drugs, Investigational
1
2015
31
0.440
 Why?
Neovascularization, Pathologic
2
2013
286
0.430
 Why?
Healthcare Disparities
1
2021
725
0.420
 Why?
Relaxation Therapy
1
2014
19
0.410
 Why?
Leisure Activities
1
2014
30
0.410
 Why?
Stroke Rehabilitation
1
2014
43
0.400
 Why?
Adenocarcinoma
5
2023
927
0.400
 Why?
Pyrazines
2
2018
92
0.390
 Why?
Microsatellite Repeats
2
2024
157
0.380
 Why?
Drug Evaluation, Preclinical
1
2013
194
0.380
 Why?
Immunoglobulin G
1
2017
893
0.380
 Why?
Clinical Trials as Topic
4
2025
1050
0.380
 Why?
Drug Design
1
2013
173
0.370
 Why?
ErbB Receptors
5
2017
627
0.370
 Why?
Xenograft Model Antitumor Assays
7
2025
928
0.340
 Why?
Carcinoma, Signet Ring Cell
1
2011
17
0.340
 Why?
Cell Transformation, Neoplastic
1
2013
339
0.340
 Why?
Terminal Care
1
2015
279
0.330
 Why?
Carcinoma, Squamous Cell
2
2026
641
0.320
 Why?
Imidazoles
2
2024
254
0.320
 Why?
Fibroblast Growth Factors
1
2011
188
0.320
 Why?
Organoplatinum Compounds
3
2026
66
0.310
 Why?
Dose-Response Relationship, Drug
3
2025
2026
0.310
 Why?
src-Family Kinases
1
2010
93
0.300
 Why?
Clinical Decision-Making
4
2024
358
0.290
 Why?
Genomics
4
2025
833
0.290
 Why?
Maximum Tolerated Dose
2
2025
212
0.290
 Why?
Patient Selection
3
2019
719
0.290
 Why?
Disease Management
4
2021
643
0.280
 Why?
Boronic Acids
1
2008
37
0.280
 Why?
Aged, 80 and over
14
2026
8243
0.280
 Why?
Janus Kinase 2
1
2008
29
0.270
 Why?
Myeloproliferative Disorders
1
2008
19
0.270
 Why?
Stomach Neoplasms
3
2022
126
0.270
 Why?
Etoposide
1
2008
166
0.270
 Why?
Carboplatin
1
2008
160
0.270
 Why?
Patient-Centered Care
2
2025
540
0.260
 Why?
Carcinoembryonic Antigen
2
2024
38
0.260
 Why?
Pathology, Molecular
2
2017
25
0.250
 Why?
Shock, Septic
1
2009
215
0.250
 Why?
Pathology, Clinical
2
2017
29
0.250
 Why?
Cancer Survivors
2
2024
326
0.250
 Why?
Health Services Accessibility
1
2015
1091
0.240
 Why?
Drug Administration Schedule
4
2019
778
0.240
 Why?
Organ Sparing Treatments
1
2026
38
0.240
 Why?
B7-H1 Antigen
3
2026
241
0.230
 Why?
Oncology Service, Hospital
1
2025
15
0.230
 Why?
ras Proteins
2
2017
150
0.230
 Why?
Anus Neoplasms
1
2026
32
0.230
 Why?
Ipilimumab
1
2026
39
0.230
 Why?
CD47 Antigen
1
2025
42
0.230
 Why?
Age Factors
5
2021
3313
0.220
 Why?
Diagnosis, Differential
1
2009
1487
0.220
 Why?
United States
14
2025
15876
0.220
 Why?
Oximes
1
2024
26
0.210
 Why?
Fluorescence Resonance Energy Transfer
1
2025
178
0.210
 Why?
Young Adult
6
2026
13990
0.210
 Why?
Benchmarking
1
2025
188
0.210
 Why?
CD3 Complex
1
2024
111
0.200
 Why?
Prognosis
10
2026
4278
0.200
 Why?
Cell Line, Tumor
6
2025
3539
0.200
 Why?
Deoxycytidine
3
2024
221
0.200
 Why?
Metastasectomy
1
2023
19
0.200
 Why?
Antibodies, Bispecific
1
2024
64
0.200
 Why?
Extracellular Vesicles
1
2025
170
0.190
 Why?
Trifluridine
1
2022
3
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2022
77
0.190
 Why?
Retrospective Studies
11
2026
17009
0.190
 Why?
Signal Transduction
6
2018
5221
0.190
 Why?
Neoplasm Grading
2
2024
307
0.190
 Why?
Surgical Oncology
1
2022
30
0.190
 Why?
Clinical Trials, Phase III as Topic
2
2022
117
0.180
 Why?
Academic Medical Centers
1
2025
545
0.180
 Why?
Empathy
1
2024
181
0.180
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
169
0.180
 Why?
Genetic Testing
3
2022
478
0.180
 Why?
Ovarian Neoplasms
2
2020
586
0.180
 Why?
Databases, Factual
4
2017
1484
0.180
 Why?
Membrane Proteins
3
2019
1165
0.180
 Why?
Disease Models, Animal
4
2021
4556
0.180
 Why?
Chemoradiotherapy, Adjuvant
2
2023
44
0.170
 Why?
Survival Rate
6
2023
2088
0.170
 Why?
Incidence
6
2022
2870
0.170
 Why?
Gene Regulatory Networks
1
2024
318
0.170
 Why?
Tumor Microenvironment
2
2023
732
0.170
 Why?
Neoplasms, Multiple Primary
1
2022
58
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
40
0.170
 Why?
DNA
1
2008
1460
0.170
 Why?
Pheochromocytoma
1
2022
58
0.170
 Why?
Meningioma
1
2022
86
0.170
 Why?
Capecitabine
2
2022
57
0.160
 Why?
Congresses as Topic
2
2019
221
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Health Status Disparities
2
2020
321
0.160
 Why?
Practice Patterns, Physicians'
1
2009
1347
0.150
 Why?
Artificial Intelligence
1
2024
365
0.150
 Why?
Immune System
1
2021
179
0.150
 Why?
Adenomatous Polyposis Coli Protein
1
2019
20
0.150
 Why?
Smad4 Protein
1
2019
34
0.150
 Why?
Area Under Curve
2
2018
329
0.150
 Why?
Retinal Vein
1
2019
13
0.150
 Why?
GTP Phosphohydrolases
1
2019
93
0.150
 Why?
Tumor Suppressor Protein p53
2
2022
529
0.140
 Why?
Prevalence
2
2026
2815
0.140
 Why?
Cell-Free Nucleic Acids
1
2019
33
0.140
 Why?
Animals
12
2025
38030
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
108
0.140
 Why?
Vasculitis
1
2019
68
0.140
 Why?
Disease Progression
4
2017
2840
0.140
 Why?
Genes, ras
1
2018
96
0.140
 Why?
Neoplasm Transplantation
1
2018
251
0.130
 Why?
Evidence-Based Medicine
2
2019
729
0.130
 Why?
Retinal Diseases
1
2019
99
0.130
 Why?
Proportional Hazards Models
3
2017
1322
0.130
 Why?
Drug Combinations
2
2022
390
0.130
 Why?
Survivorship
1
2018
54
0.130
 Why?
Patient Advocacy
1
2018
73
0.130
 Why?
Cohort Studies
6
2020
5935
0.130
 Why?
Acneiform Eruptions
1
2017
1
0.130
 Why?
Asthenia
1
2017
3
0.130
 Why?
Population Surveillance
1
2021
483
0.130
 Why?
Risk Factors
6
2022
10699
0.130
 Why?
Risk Assessment
2
2019
3637
0.130
 Why?
Drug Eruptions
1
2017
28
0.130
 Why?
Hypokalemia
1
2017
24
0.130
 Why?
Histone Deacetylase Inhibitors
1
2019
220
0.130
 Why?
MAP Kinase Kinase 1
1
2017
71
0.130
 Why?
Receptor, ErbB-3
1
2017
48
0.130
 Why?
Patient Compliance
1
2021
585
0.130
 Why?
Intercellular Signaling Peptides and Proteins
2
2015
381
0.130
 Why?
Consensus
1
2019
488
0.130
 Why?
Esophageal Neoplasms
1
2021
346
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.120
 Why?
Digestive System Neoplasms
1
2016
9
0.120
 Why?
Antineoplastic Agents, Immunological
1
2019
199
0.120
 Why?
Neoplasm Recurrence, Local
2
2023
1137
0.120
 Why?
Liver Neoplasms
2
2024
780
0.120
 Why?
Adolescent
5
2026
22281
0.120
 Why?
Edema
1
2016
124
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
319
0.120
 Why?
Hospitals
1
2021
727
0.120
 Why?
Time Factors
2
2019
7155
0.120
 Why?
Triple Negative Breast Neoplasms
1
2019
215
0.120
 Why?
Biomarkers
3
2023
4254
0.120
 Why?
Biliary Tract Neoplasms
1
2015
30
0.120
 Why?
GPI-Linked Proteins
1
2016
80
0.120
 Why?
Diabetic Neuropathies
1
2016
97
0.120
 Why?
Device Approval
1
2015
19
0.110
 Why?
Immunoblotting
1
2015
300
0.110
 Why?
Receptor, Notch1
1
2015
64
0.110
 Why?
Mice
7
2025
18329
0.110
 Why?
Neuralgia
1
2016
144
0.110
 Why?
Patient Care Planning
1
2016
169
0.110
 Why?
Health Behavior
1
2020
782
0.110
 Why?
Gene Dosage
1
2015
148
0.110
 Why?
Analgesics
1
2016
228
0.110
 Why?
Pancreas
1
2017
341
0.110
 Why?
Delivery of Health Care, Integrated
1
2018
297
0.110
 Why?
Gene Expression Regulation
1
2024
2603
0.110
 Why?
Administration, Oral
1
2017
847
0.110
 Why?
Drug Approval
1
2015
89
0.110
 Why?
DNA Copy Number Variations
1
2015
183
0.110
 Why?
Quality of Life
2
2024
3166
0.110
 Why?
Immunoconjugates
1
2016
132
0.100
 Why?
Genetic Variation
1
2019
982
0.100
 Why?
Quinazolines
1
2015
266
0.100
 Why?
United States Food and Drug Administration
1
2015
203
0.100
 Why?
Phenotype
2
2021
3157
0.100
 Why?
Delivery of Health Care
1
2021
940
0.100
 Why?
Proto-Oncogene Proteins
1
2017
623
0.100
 Why?
Liquid Biopsy
2
2025
13
0.100
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
758
0.100
 Why?
beta Catenin
1
2015
252
0.100
 Why?
Lung Neoplasms
2
2024
2637
0.100
 Why?
Lymphocytes
1
2015
382
0.100
 Why?
Spinal Cord Injuries
1
2016
240
0.100
 Why?
National Cancer Institute (U.S.)
2
2025
52
0.100
 Why?
Randomized Controlled Trials as Topic
1
2019
1705
0.090
 Why?
Registries
1
2021
2382
0.090
 Why?
Protein Kinase Inhibitors
1
2018
968
0.090
 Why?
Risk
1
2014
909
0.090
 Why?
Angiogenesis Inhibitors
1
2013
236
0.090
 Why?
Ligands
1
2013
673
0.090
 Why?
Neoplasm, Residual
2
2022
139
0.080
 Why?
Prospective Studies
3
2022
7970
0.080
 Why?
Patient Care Team
1
2016
686
0.080
 Why?
Protein-Tyrosine Kinases
1
2013
433
0.080
 Why?
Activities of Daily Living
1
2014
440
0.080
 Why?
Apoptosis
3
2022
2430
0.080
 Why?
Mice, Nude
2
2024
682
0.080
 Why?
Streptococcaceae
1
2009
2
0.080
 Why?
Cytokines
2
2015
2061
0.070
 Why?
Clinical Medicine
1
2009
26
0.070
 Why?
Neutrophils
1
2015
1134
0.070
 Why?
Patient Satisfaction
1
2013
704
0.070
 Why?
Transcriptome
1
2015
1044
0.070
 Why?
Chemoradiotherapy
2
2023
237
0.070
 Why?
Myositis
1
2009
57
0.070
 Why?
Sulindac
1
2008
16
0.070
 Why?
Bortezomib
1
2008
55
0.070
 Why?
Mutation Rate
2
2019
30
0.070
 Why?
Taiwan
1
2008
46
0.070
 Why?
Combined Modality Therapy
1
2011
1264
0.070
 Why?
Nausea
1
2008
111
0.070
 Why?
Immunoenzyme Techniques
1
2008
200
0.070
 Why?
Multivariate Analysis
3
2017
1533
0.070
 Why?
Neutropenia
1
2008
155
0.070
 Why?
Fluphenazine
1
2007
4
0.070
 Why?
Risperidone
1
2007
29
0.060
 Why?
Nerve Fibers, Myelinated
1
2007
47
0.060
 Why?
Drug Therapy, Combination
1
2010
1044
0.060
 Why?
Food
1
2008
149
0.060
 Why?
Exons
1
2008
358
0.060
 Why?
Anemia
1
2008
187
0.060
 Why?
Fasting
1
2008
276
0.060
 Why?
Thrombocytopenia
1
2008
205
0.060
 Why?
Frontal Lobe
1
2007
159
0.060
 Why?
Gastrectomy
2
2017
157
0.060
 Why?
Administrative Personnel
1
2025
33
0.060
 Why?
Propensity Score
2
2017
367
0.060
 Why?
Antipsychotic Agents
1
2007
207
0.060
 Why?
Polymerase Chain Reaction
1
2008
1054
0.050
 Why?
Stroke
1
2014
1254
0.050
 Why?
Postoperative Complications
1
2017
2916
0.050
 Why?
Follow-Up Studies
2
2026
5389
0.050
 Why?
Loneliness
1
2024
59
0.050
 Why?
Survival Analysis
2
2017
1382
0.050
 Why?
Fluorescent Dyes
1
2025
329
0.050
 Why?
Health Care Surveys
1
2025
538
0.050
 Why?
Delayed Diagnosis
1
2024
94
0.050
 Why?
Natural Language Processing
1
2024
103
0.050
 Why?
Oxidative Stress
1
2010
1339
0.050
 Why?
Thymine
1
2022
17
0.050
 Why?
Cyclooxygenase 2 Inhibitors
1
2022
23
0.050
 Why?
Paclitaxel
1
2024
255
0.050
 Why?
G2 Phase Cell Cycle Checkpoints
1
2022
44
0.050
 Why?
Equivalence Trials as Topic
1
2022
35
0.050
 Why?
Mice, Inbred BALB C
1
2025
1253
0.050
 Why?
Recombinant Fusion Proteins
1
2025
674
0.050
 Why?
Endothelial Growth Factors
1
2022
64
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
 Why?
Resilience, Psychological
1
2024
135
0.050
 Why?
Gallium Radioisotopes
1
2022
15
0.050
 Why?
Radioisotopes
1
2022
33
0.050
 Why?
Receptors, Peptide
1
2022
18
0.050
 Why?
Organoids
1
2024
141
0.050
 Why?
Radionuclide Imaging
1
2022
112
0.050
 Why?
Intestinal Neoplasms
1
2022
30
0.050
 Why?
Inflammasomes
1
2023
146
0.040
 Why?
Pyrrolidines
1
2022
125
0.040
 Why?
Neoplastic Syndromes, Hereditary
1
2021
45
0.040
 Why?
Radiopharmaceuticals
1
2022
194
0.040
 Why?
North America
1
2022
310
0.040
 Why?
Quinolines
1
2022
190
0.040
 Why?
Europe
1
2022
412
0.040
 Why?
Positron Emission Tomography Computed Tomography
1
2022
117
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Immune Tolerance
1
2023
379
0.040
 Why?
Preventive Medicine
1
2021
39
0.040
 Why?
Lymphocyte Subsets
1
2021
83
0.040
 Why?
Canada
1
2022
428
0.040
 Why?
Surveys and Questionnaires
2
2024
6021
0.040
 Why?
Lymphoid Tissue
1
2021
80
0.040
 Why?
Hyaluronic Acid
1
2022
208
0.040
 Why?
Positron-Emission Tomography
1
2022
323
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Geography
1
2020
203
0.040
 Why?
Morbidity
1
2021
323
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
230
0.040
 Why?
SEER Program
1
2020
224
0.040
 Why?
Mice, Inbred C57BL
2
2023
5988
0.040
 Why?
Mice, Inbred NOD
1
2021
610
0.040
 Why?
Spectrophotometry, Infrared
1
2019
55
0.040
 Why?
District of Columbia
1
2018
35
0.040
 Why?
Sulfonamides
1
2022
580
0.040
 Why?
Karnofsky Performance Status
1
2018
37
0.040
 Why?
Pyridines
1
2022
605
0.030
 Why?
Structure-Activity Relationship
1
2019
567
0.030
 Why?
Multimodal Imaging
1
2019
124
0.030
 Why?
Melanoma
1
2024
760
0.030
 Why?
Fluorescein Angiography
1
2019
184
0.030
 Why?
Colon
1
2020
304
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2019
154
0.030
 Why?
Half-Life
1
2017
151
0.030
 Why?
American Medical Association
1
2017
19
0.030
 Why?
RNA
1
2024
939
0.030
 Why?
Genome, Human
1
2019
422
0.030
 Why?
Gene Expression Profiling
1
2024
1782
0.030
 Why?
Tomography, Optical Coherence
1
2019
264
0.030
 Why?
Needles
1
2016
62
0.030
 Why?
Reproducibility of Results
1
2024
3403
0.030
 Why?
Radiotherapy, Adjuvant
1
2017
222
0.030
 Why?
Cell Proliferation
1
2024
2494
0.030
 Why?
Delphi Technique
1
2018
329
0.030
 Why?
Infusions, Intravenous
1
2017
423
0.030
 Why?
Genomic Instability
1
2017
66
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2017
141
0.030
 Why?
Health Services Needs and Demand
1
2018
279
0.030
 Why?
Molecular Diagnostic Techniques
1
2017
104
0.030
 Why?
Meta-Analysis as Topic
1
2017
172
0.030
 Why?
Retreatment
1
2016
77
0.030
 Why?
Algorithms
1
2024
1834
0.030
 Why?
DNA Mutational Analysis
1
2017
405
0.030
 Why?
Incidental Findings
1
2016
80
0.030
 Why?
Acute Disease
1
2019
1028
0.030
 Why?
Platinum
1
2016
50
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Gene Frequency
1
2017
481
0.030
 Why?
Jagged-1 Protein
1
2015
22
0.030
 Why?
Neoplasm Invasiveness
1
2017
508
0.030
 Why?
Radiography
2
2016
842
0.030
 Why?
Gene Duplication
1
2015
67
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
674
0.030
 Why?
Endoscopy, Digestive System
1
2016
140
0.030
 Why?
Protein Isoforms
1
2016
402
0.030
 Why?
Practice Guidelines as Topic
1
2022
1559
0.030
 Why?
Preoperative Care
1
2017
379
0.030
 Why?
Leukocyte Count
1
2015
316
0.030
 Why?
Magnetic Resonance Imaging
1
2007
3857
0.030
 Why?
Analysis of Variance
1
2017
1304
0.030
 Why?
Calcium-Binding Proteins
1
2015
219
0.030
 Why?
Ultraviolet Rays
1
2016
387
0.030
 Why?
Mice, Knockout
1
2021
3119
0.030
 Why?
Societies, Medical
1
2018
886
0.030
 Why?
Behavior, Animal
1
2016
519
0.020
 Why?
Protein Processing, Post-Translational
1
2016
477
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
917
0.020
 Why?
Brain Neoplasms
1
2021
1318
0.020
 Why?
Logistic Models
1
2017
2104
0.020
 Why?
Skin
1
2016
754
0.020
 Why?
Immunohistochemistry
1
2016
1715
0.020
 Why?
Rats, Sprague-Dawley
1
2016
2525
0.020
 Why?
Cross-Sectional Studies
1
2022
5813
0.020
 Why?
Lung
1
2023
4108
0.020
 Why?
Angiogenesis Inducing Agents
1
2009
26
0.020
 Why?
Protein Binding
1
2016
2270
0.020
 Why?
Glycogen Synthase Kinase 3 beta
1
2008
72
0.020
 Why?
Rats
1
2016
5592
0.020
 Why?
Glycogen Synthase Kinase 3
1
2008
81
0.020
 Why?
Reference Standards
1
2008
177
0.020
 Why?
Pharmacogenetics
1
2008
172
0.020
 Why?
Infusions, Intra-Arterial
1
1986
61
0.010
 Why?
Hepatic Artery
1
1986
53
0.010
 Why?
Chromatography, High Pressure Liquid
1
2008
593
0.010
 Why?
Breast Neoplasms
1
2019
2447
0.010
 Why?
Reference Values
1
2007
797
0.010
 Why?
Predictive Value of Tests
1
2011
2111
0.010
 Why?
Tomography, X-Ray Computed
1
2016
2730
0.010
 Why?
Tandem Mass Spectrometry
1
2008
576
0.010
 Why?
Image Processing, Computer-Assisted
1
2007
780
0.010
 Why?
Longitudinal Studies
1
2007
2926
0.010
 Why?
Lieu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (416) concept(s)
_
Co-Authors Expand Description
See all (78) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)